Drug Corporations’ Greed Knows No End

Sign This Petition

- You may receive email updates from Social Security Works, the sponsor of this petition.
- Edit Subscription Preferences Close Preferences
- - Opt in to email updates from Social Security Works

Drug Corporations’ Greed Knows No End

All Members of Congress

In 1983, Congress passed the Orphan Drug Act with the intent of spurring innovation for drugs that treat rare diseases.

But today, pharmaceutical corporations are exploiting loopholes in the law in order to gain even greater monopoly power and reap ever more massive profits. But apparently that wasn’t enough, because now, prescription drug companies and their Washington lobbyists are pushing a new bill―the Orphan Product Extensions Now (OPEN) Act―which would grant drug manufacturers six additional months of exclusivity.

It’s estimated that this new law would cost patients and taxpayers up to $11.6 billion over 10 years―padding the pockets of the greedy pharmaceutical industry and keeping our drug prices the highest in the world.

Stand with Social Security Works to oppose the OPEN Act and say no to drug company monopolies.

Sponsored by

Social Security Works

To: All Members of Congress
From: [Your Name]

The Orphan Product Extensions Now (OPEN) Act is nothing more than a blatant money grab by the greedy pharmaceutical industry. If passed, this bill would allow drug companies to repurpose “blockbuster” drugs that are already on the market, giving them “orphan” status and providing drug manufacturers an additional six months of exclusivity. It’s estimated that this additional exclusivity period would cost patients and taxpayers up to $11.6 billion over 10 years. We demand that you oppose the OPEN Act and say no to drug company monopolies.